These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35232006)

  • 1. Incidence and Cognitive Decline of Alzheimer's Disease and Other Dementia by Apolipoprotein ε4 Allele Presence: A Community-Based Cohort Study in Korean Elderly.
    Yoo SY; Han A; Park S; Lee JY
    Psychiatry Investig; 2022 Mar; 19(3):190-196. PubMed ID: 35232006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of apolipoprotein E ε4 allele on the progression of cognitive decline in the early stage of Alzheimer's disease.
    Suzuki K; Hirakawa A; Ihara R; Iwata A; Ishii K; Ikeuchi T; Sun CK; Donohue M; Iwatsubo T;
    Alzheimers Dement (N Y); 2020; 6(1):e12007. PubMed ID: 32211510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased Function of Delayed Recall in Non-demented Elderly Subjects With Apolipoprotein E ε4 Allele.
    Wang L; Pan X; Fei G; Wang C; Wan W; Sang S; Wang H; Wang Z; Zhong C
    Front Aging Neurosci; 2019; 11():71. PubMed ID: 30983990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
    Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA
    Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.
    Craft S; Teri L; Edland SD; Kukull WA; Schellenberg G; McCormick WC; Bowen JD; Larson EB
    Neurology; 1998 Jul; 51(1):149-53. PubMed ID: 9674794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOE ε4 influences cognitive decline positively in APP and negatively in PSEN1 mutation carriers with autosomal-dominant Alzheimer's disease.
    Almkvist O; Johansson C; Laffita-Mesa J; Thordardottir S; Graff C
    Eur J Neurol; 2022 Dec; 29(12):3580-3589. PubMed ID: 36039401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.
    Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO
    BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY; Sadovnick AD; Feldman H
    CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.
    Yip AG; Brayne C; Easton D; Rubinsztein DC;
    J Med Genet; 2002 Sep; 39(9):639-43. PubMed ID: 12205106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease.
    Suh GH; Jung HY; Lee CU; Oh BH; Lee SK; Lee N; Kim J; Kee BS; Ko D; Kim YH; Ju YS; Hong I; Choi S;
    Dement Geriatr Cogn Disord; 2006; 21(1):33-9. PubMed ID: 16254428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
    Qiu C; Winblad B; Fratiglioni L
    Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older population.
    Riaz M; Huq A; Ryan J; Orchard SG; Tiller J; Lockery J; Woods RL; Wolfe R; Renton AE; Goate AM; Sebra R; Schadt E; Brodtmann A; Shah RC; Storey E; Murray AM; McNeil JJ; Lacaze P
    Aging Cell; 2021 Jun; 20(6):e13384. PubMed ID: 34041846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease.
    Minthon L; Hesse C; Sjögren M; Englund E; Gustafson L; Blennow K
    Neurosci Lett; 1997 Apr; 226(1):65-7. PubMed ID: 9153643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
    Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
    J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E (APOE) ε4 and episodic memory decline in Alzheimer's disease: A review.
    El Haj M; Antoine P; Amouyel P; Lambert JC; Pasquier F; Kapogiannis D
    Ageing Res Rev; 2016 May; 27():15-22. PubMed ID: 26876367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia.
    Jonker C; Schmand B; Lindeboom J; Havekes LM; Launer LJ
    Arch Neurol; 1998 Aug; 55(8):1065-9. PubMed ID: 9708956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in risk of Alzheimer's disease in adults with Down syndrome.
    Lai F; Mhatre PG; Yang Y; Wang MC; Schupf N; Rosas HD
    Alzheimers Dement (Amst); 2020; 12(1):e12084. PubMed ID: 32995462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AD Resemblance Atrophy Index of Brain Magnetic Resonance Imaging in Predicting the Progression of Mild Cognitive Impairment Carrying Apolipoprotein E-ε4 Allele.
    Mai Y; Cao Z; Xu J; Yu Q; Yang S; Tang J; Zhao L; Fang W; Luo Y; Lei M; Mok VCT; Shi L; Liao W; Liu J;
    Front Aging Neurosci; 2022; 14():859492. PubMed ID: 35572149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E genotype, dementia, and mortality in the oldest old: the 90+ Study.
    Corrada MM; Paganini-Hill A; Berlau DJ; Kawas CH
    Alzheimers Dement; 2013 Jan; 9(1):12-8. PubMed ID: 23123227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.